GobyMeds vs Hers: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: GobyMeds scores higher on our rubric, 8.4/10 against 7.3/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit Hers - $188 first month, then $298/mo →or find your match

GobyMeds beats Hers overall, scoring 8.4/10 vs 7.3/10. Published pricing is not a like-for-like monthly comparison: GobyMeds is from $99/mo; Hers is $188 first month, then $298/mo. Choose GobyMeds for budget-conscious users who want a modern, well-reviewed compounded glp-1 program. Choose Hers for women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path.

A side-by-side look at GobyMeds and Hers to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

GobyMeds

#2 of 54

8.4/10

Fast-growing compounded GLP-1 provider with strong Reddit reviews, competitive pricing, and a clean user experience that punches above its price point.

Visit GobyMeds

Hers

#30 of 54

7.3/10

The women's health arm of Hims & Hers Health (NYSE: HIMS). Hers lists Wegovy pill, Foundayo, and Ozempic pill medication from $149, a Wegovy pen from $199, Zepbound from $299, and compounded options. A required Weight Loss Membership adds $39 in month one and $149/mo thereafter, so the all-in floor for a $149 medication path is $188 initially and $298/mo ongoing; exact product and dose prices vary.

Visit Hers

Feature	GobyMeds	Hers
Why each one	The best value in compounded GLP-1s, $169/mo standard monthly ($99/mo on the 3-month starter bundle) with a user experience and support quality that rivals platforms charging 50-75% more.	A major women-focused telehealth platform with a direct Novo Nordisk partnership (Wegovy pill from $149 and pen from $199 before required membership) and a Lilly partnership (Zepbound medication from $299) alongside compounded options.
Our Score	8.4/10	7.3/10
Headline Price	from $99/mo	$188 first month, then $298/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Budget-conscious users who want a modern, well-reviewed compounded GLP-1 program	Women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path
Watch out for	Tirzepatide and brand-name options added 2026 but at much higher price points ($299/mo+), the semaglutide program is the value story	Pending federal enforcement action against the parent company. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings.
Ranking	#2	#30
Get started	Visit GobyMeds	Visit Hers

Pros & Cons Compared

GobyMeds

Pros

+$169/mo standard monthly rate, or $99/mo on the 3-month starter bundle, among the most affordable for a full-service compounded program
+Consistently positive Reddit reviews citing fast shipping, responsive support, and clean UX
+Modern patient portal with real-time order tracking and easy provider messaging
+Quick onboarding, most patients approved and shipped within 48 hours of enrollment

Cons

−Tirzepatide and brand-name options added 2026 but at much higher price points ($299/mo+), the semaglutide program is the value story
−Newer company with less track record than established players like Ro or Hims
−No insurance billing and no superbills for FSA/HSA reimbursement

Hers

Pros

+FDA-approved brand paths include Wegovy pill, Foundayo, and Ozempic pill medication from $149 and a Wegovy pen from $199; with the required membership, a $149 medication path totals $188 initially and $298/mo ongoing
+Zepbound access via the Lilly/Hims-Hers partnership announced 2026
+Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
+Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services

Cons

−Pending federal enforcement action against the parent company. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings.
−Every medication figure excludes the required Weight Loss Membership ($39 first month, then $149/mo); exact product and dose prices can increase the total above the $188/$298 floor
−Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
−Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
−Zepbound medication starts at $299 before the required membership; that path totals $338 in month one and at least $448/mo ongoing, with exact dose pricing potentially higher

Our Verdict

GobyMeds edges out Hers with a score of 8.4/10 vs 7.3/10. Published pricing is not a like-for-like monthly comparison: GobyMeds is from $99/mo; Hers is $188 first month, then $298/mo.